Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Haiyang Zhou
Observed name:
Zhou, Haiyang
Institution:
Nanjing University of Chinese Medicine
Observed institutions:
Nanjing University of Chinese Medicine,
Ningxia Medical University,
Changzhou No.2 People's Hospital,
Nanjing Medical University
ORCID:
0009-0004-6920-9942
Observed ORCID:
0009-0004-6920-9942
OpenAlex ID:
A5078532216
Current status of and barriers to the treatment of advanced-stage liver cancer in China: a questionnaire-based study from the perspective of doctors
2022
·
Qiaoxin Wei
, Haiyang Zhou
, et al.
·
BMC Gastroenterology
·
12
PDF
Role of signaling pathways in lung cancer development and advances in targeted therapies (Review)
2025
·
Zhang Tao
, Weiwei Shao
, et al.
·
Oncology Letters
·
7
PDF
Comprehensive Pan-Cancer Analysis of MTF2 Effects on Human Tumors
2023
·
Cui Tang
, Ye Lv
, et al.
·
Current Problems in Cancer
·
5
Identifying the Crucial Biomarker of MASH-Related HCC
2024
·
Haiyang Zhou
, Yinjie Zhang
, et al.
·
Combinatorial Chemistry & High Throughput Screening
·
3
Show more works
View as search
Works count:
7
Citation count:
27
H-index:
3
I10-index:
1
Year
Topic
Type